Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Blood Cancer J
; 6: e418, 2016 05 06.
Article
in En
| MEDLINE
| ID: mdl-27152845
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Marrow
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Blast Crisis
/
Sarcoma, Myeloid
/
Protein Kinase Inhibitors
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2016
Document type:
Article
Affiliation country:
Estados Unidos